In a bold play to cement its status as a leader in advanced additive manufacturing, AML3D Limited (ASX: AL3) has secured a $30 million capital injection. The funds, raised through a heavily oversubscribed placement, will supercharge the company's US expansion efforts while laying groundwork for its European ambitions. With a share placement priced at $0.19 per share—a 17.4% discount to its last traded price—the Adelaide-based innovator is ready to take its ARCEMY® technology to new heights.
Doubling Down in the US
AML3D’s Managing Director, Sean Ebert, called the successful placement a “significant milestone,” reflecting strong investor confidence in the company's trajectory. A sizeable $12 million of the funds will be allocated to expanding its Stowe, Ohio, Technology Centre, which is set to more than double its manufacturing capacity. The enhanced facility will include up to four additional ARCEMY® systems for producing advanced metal parts, supporting an expected surge in demand from the US Navy and other defence players.
The move aligns with the US Department of Defense’s $951 million funding boost for the Submarine Industrial Base (SIB), which AML3D is well-positioned to support. Through its partnership with Blue Forge Alliance, a non-profit integrator tasked with bolstering the SIB, AML3D’s ARCEMY® technology has already made significant inroads. Ebert confirmed that “a reasonable proportion of the new funds will be directed to scaling up and integrating additive manufacturing into the US Navy’s Submarine Industrial Base.”
Beyond Defence
While defence remains a cornerstone of AML3D’s strategy, the company is eyeing other lucrative sectors, such as energy and aerospace. Its Manufacturing Licence Agreement with Boeing is a case in point, allowing AML3D to produce high-performance aircraft components—a testament to its technological prowess and growing market appeal.
Pete Goumas, AML3D’s US President, described the momentum stateside: “In just over a year, we’ve established a state-of-the-art facility in Ohio and built a stellar team. This surge in defence-related investment is a huge opportunity, and we’re ready to scale rapidly to meet demand.”
Cracking Europe
AML3D isn’t content with dominating the US; it has its sights set on Europe, where it plans to establish a showcase facility with a single ARCEMY® unit. Leveraging the strategic backdrop of AUKUS, the trilateral security pact, AML3D sees similar demand signals to those it encountered in the US market. The European base will serve as both a demonstration hub and a launchpad for market penetration.
Innovating for the Future
Around $3 million of the raise will go into research and development, ensuring AML3D stays at the cutting edge of additive manufacturing. Its proprietary Wire Additive Manufacturing (WAM®) technology already leads the pack, blending welding science, robotics, and materials engineering to deliver parts faster, cheaper, and with lower environmental impact than traditional methods.
This investment will broaden WAM® applications and sharpen its competitive edge, particularly in defence, where rapid prototyping and customisation are paramount.
The Investment Case
The two-tranche placement underscores investor appetite for AML3D’s growth story. Institutional backers flocked to the raise, which was managed by Bell Potter Securities and Shaw and Partners Limited. The first tranche, utilising the company’s existing placement capacity, raised $17.9 million. A second tranche of $12.1 million, subject to shareholder approval at a December meeting, will round out the funding.
The placement price reflects an 18.1% discount to AML3D’s five-day volume-weighted average price, a level that investors clearly found attractive given the oversubscription.
What’s Next?
The next key date on AML3D’s calendar is 20 December, when shareholders will vote on the second tranche of funding. Meanwhile, the company’s shares resumed trading today, with market watchers eager to see how the ambitious plans resonate with investors.
AML3D has positioned itself as a trailblazer in additive manufacturing, combining cutting-edge technology with strategic foresight. As defence contracts and global reshoring initiatives drive demand for its ARCEMY® systems, the $30 million raise is both a validation of its vision and a catalyst for further growth.
The company’s rapid scaling in the US and calculated entry into Europe make it one to watch—not just for defence enthusiasts but for anyone intrigued by the future of manufacturing.
